0001815624-20-000001.txt : 20200619 0001815624-20-000001.hdr.sgml : 20200619 20200619124802 ACCESSION NUMBER: 0001815624-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200619 DATE AS OF CHANGE: 20200619 EFFECTIVENESS DATE: 20200619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GelMEDIX, Inc. CENTRAL INDEX KEY: 0001815624 IRS NUMBER: 881188838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369335 FILM NUMBER: 20975062 BUSINESS ADDRESS: STREET 1: 90 BRIDGE STREET CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: 617-500-3455 MAIL ADDRESS: STREET 1: 90 BRIDGE STREET CITY: NEWTON STATE: MA ZIP: 02458 D 1 primary_doc.xml X0708 D LIVE 0001815624 GelMEDIX, Inc. 90 BRIDGE STREET NEWTON MA MASSACHUSETTS 02458 617-500-3455 DELAWARE None None Corporation true 2020 Reza Dana 90 Bridge Street Newton MA MASSACHUSETTS 02458 Director Nasim Annabi 90 Bridge Street Newton MA MASSACHUSETTS 02458 Director Jeffrey Behrens 90 Bridge Street Newton MA MASSACHUSETTS 02458 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-06-04 false true true false 10000 1000000 250000 750000 false 1 0 0 0 false GelMEDIX, Inc. Jeffrey Behrens Jeffrey Behrens Chief Executive Officer 2020-06-19